Jacob Asset Management of New York’s IDEAYA Biosciences IDYA Stock Holding History

Jacob Asset Management of New York’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$920K	Sell	34,103 -4,925	-13%	-$125K	1.3%	33
2023 Q2	$917K	Sell	39,028 -5,708	-13%	-$117K	1.03%	36
2023 Q1	$614K	Sell	44,736 -2,776	-6%	-$46.2K	0.72%	42
2022 Q4	$863K	Sell	47,512 -26,757	-36%	-$450K	1.05%	31
2022 Q3	$1.11M	Buy	74,269 +19,135	+35%	+$249K	1.2%	29
2022 Q2	$761K	Sell	55,134 -7,795	-12%	-$86.7K	0.77%	37
2022 Q1	$704K	Buy	62,929 +11,047	+21%	+$163K	0.43%	46
2021 Q4	$1.23M	Sell	51,882 -2,693	-5%	-$62.6K	0.55%	43
2021 Q3	$1.39M	Buy	54,575 +2,875	+6%	+$67.1K	0.51%	49
2021 Q2	$1.08M	Sell	51,700 -2,300	-4%	-$47.2K	0.36%	62
2021 Q1	$1.27M	Buy	54,000 +18,000	+50%	+$347K	0.49%	53
2020 Q4	$504K	Buy	+36,000	New	+$488K	0.38%	49

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jacob Asset Management of New York's IDYA Position: Q3 2023 in Review

Jacob Asset Management of New York reduced its IDEAYA Biosciences (IDYA) stake by 13% in Q3 2023, selling an estimated $125K and leaving 34,103 shares worth $920K. The position accounts for 1.3% of the portfolio, ranked #33.

Jacob Asset Management of New York first reported a position in IDYA in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2021. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

Jacob Asset Management of New York held 34,103 shares of IDEAYA Biosciences worth $920K as of Q3 2023.
Jacob Asset Management of New York sold 4,925 IDEAYA Biosciences shares in Q3 2023, an estimated $125K.
IDEAYA Biosciences made up 1.3% of Jacob Asset Management of New York's portfolio in Q3 2023, its #33 holding.
Jacob Asset Management of New York first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 12 quarters since.
Jacob Asset Management of New York's IDEAYA Biosciences position peaked at $1.39M in Q3 2021.
144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.